Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Zhu

Showing results (651-660 of 661) with videos related to

Pageof 67
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 27, 2022
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registryJoseph Nowatzke, Paul Guedeney, Nicholas Palaskas, et al.
Open Forum Infectious Diseases|March 31, 2023
Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican RepublicEddy Pérez-Then, Marija Miric, Han-Zhu Qian, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Bone Marrow Transplantation|November 26, 2024
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter studyJian-Ying Zhou, Yu-Xiu Chen, Hai-Long Yuan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 34 Trials including 114,326 IndividualsNada R Abuknesha, James H O'Keefe, Frank Qian, et al.
European Heart Journal|June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R Power, Charles Dolladille, Benay Ozbay, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeverityJohn R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic DysfunctionYen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
American Journal of Hematology|June 27, 2023
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMMLJian-Ying Zhou, Song Wang, Hai-Long Yuan, et al.
Pageof 67

Showing results (651-660 of 661) with videos related to

Sort By:
Pageof 67
European Journal of Cancer (Oxford, England : 1990)|August 27, 2022
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registryJoseph Nowatzke, Paul Guedeney, Nicholas Palaskas, et al.
Open Forum Infectious Diseases|March 31, 2023
Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican RepublicEddy Pérez-Then, Marija Miric, Han-Zhu Qian, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Bone Marrow Transplantation|November 26, 2024
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter studyJian-Ying Zhou, Yu-Xiu Chen, Hai-Long Yuan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 34 Trials including 114,326 IndividualsNada R Abuknesha, James H O'Keefe, Frank Qian, et al.
European Heart Journal|June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R Power, Charles Dolladille, Benay Ozbay, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeverityJohn R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic DysfunctionYen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
American Journal of Hematology|June 27, 2023
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMMLJian-Ying Zhou, Song Wang, Hai-Long Yuan, et al.
Pageof 67